$34.39
1.865.72%
Últ. Act.: Nov 6, 5:43 PM
The average analyst price target for Pharvaris is $51.22, 46.3% above the current price. Of 15 analysts, 15 rate it Buy. Targets range from $25 to $79. The latest change came on Oct 23, 2026, when B of A Securities upgraded Pharvaris from Neutral to Buy with a $44 price target.
Price Target Range — 12 Quarters
Analyst Consensus — 15 Analysts
Rating Trend — Last 9 Months